- Home
- AEVA vs ME Comparison
AEVA vs ME Comparison
Compare AEVA & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- ME
- Stock Information
- Founded
- AEVA 2019
- ME 2006
- Country
- AEVA United States
- ME United States
- Employees
- AEVA N/A
- ME N/A
- Industry
- AEVA Auto Parts:O.E.M.
- ME Precision Instruments
- Sector
- AEVA Consumer Discretionary
- ME Health Care
- Exchange
- AEVA Nasdaq
- ME Nasdaq
- Market Cap
- AEVA 241.9M
- ME 98.7M
- IPO Year
- AEVA N/A
- ME N/A
- Fundamental
- Price
- AEVA $4.17
- ME $3.39
- Analyst Decision
- AEVA Buy
- ME Hold
- Analyst Count
- AEVA 5
- ME 1
- Target Price
- AEVA $10.53
- ME $9.40
- AVG Volume (30 Days)
- AEVA 532.0K
- ME 219.4K
- Earning Date
- AEVA 03-04-2025
- ME 02-05-2025
- Dividend Yield
- AEVA N/A
- ME N/A
- EPS Growth
- AEVA N/A
- ME N/A
- EPS
- AEVA N/A
- ME N/A
- Revenue
- AEVA $7,980,000.00
- ME $193,260,000.00
- Revenue This Year
- AEVA $109.02
- ME $21.93
- Revenue Next Year
- AEVA $63.91
- ME $17.31
- P/E Ratio
- AEVA N/A
- ME N/A
- Revenue Growth
- AEVA 176.22
- ME N/A
- 52 Week Low
- AEVA $2.20
- ME $2.66
- 52 Week High
- AEVA $7.25
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- AEVA 42.53
- ME 44.56
- Support Level
- AEVA $4.08
- ME $3.15
- Resistance Level
- AEVA $5.49
- ME $4.18
- Average True Range (ATR)
- AEVA 0.40
- ME 0.26
- MACD
- AEVA -0.08
- ME 0.05
- Stochastic Oscillator
- AEVA 11.82
- ME 29.46
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.